Fig. 3From: Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE studyProportion of 5, 10 and 15 letter gainers at Month 12. BCVA, best-corrected visual acuity; ETDRS, Early Treatment Diabetic Retinopathy Study; n, number of patients with Month 12 BCVA data; OCT, optical coherence tomography; VA, visual acuityBack to article page